Persistence of Hypercoagulable State after Resection of Intra-Abdominal Malignancies
Authors:
- Robert M. Van HarenRHRobert M. Van Haren
- Mark L. RyanMRMark L. Ryan
- Emiliano CuriaECEmiliano Curia
- Danny SleemanDSDanny Sleeman
- Joe U. LeviJLJoe U. Levi
- Alan S. LivingstoneALAlan S. Livingstone
- Kenneth G. ProctorKPKenneth G. Proctor
- 1 April 2013
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 216 (4) , 580-589
Abstract
The hypercoagulable state associated with cancer imparts considerable risk for venous thromboembolism. Surgical resection of malignancies should theoretically reverse tumor-induced hypercoagulability. However, coagulation changes in cancer patients postresection have not been described thoroughly. Conventional coagulation tests are unable to detect hypercoagulable states. In contrast, rotational thromboelastography (ROTEM) can detect hypo- or hypercoagulable conditions. We hypothesized that the cancer-induced hypercoagulable state would improve after surgical resection. After informed consent, blood samples of patients undergoing surgical resection for curative intent were analyzed with serial ROTEM. Thirty-five patients (mean ± SD age 66 ± 17 years; 67% male) had cancers involving the pancreas (n = 12 [34%]), esophagus (n = 10 [29%]), stomach (n = 7 [20%]), bile ducts (n = 3 [9%]), and duodenum (n = 3 [9%]). Preoperative ROTEM identified 14 (40%) who were hypercoagulable. After surgical resection, patients became progressively hypercoagulable with more rapid clot formation time (low clot formation time, high alpha) and higher maximum clot firmness. By week one, 86% (n = 30) had abnormal ROTEM values, including 17 of 21 (81%) who had normal coagulation profiles preoperatively. Most (n = 30 [86%]) remained hypercoagulable at 3 to 4 weeks. Rotational thromboelastography identifies baseline hypercoagulability in more than one third of patients with intra-abdominal malignancies. This is among the first studies to demonstrate progressive hypercoagulability that persists for at least 1 month after resection. These data support postdischarge thromboprophylaxis regimens in high-risk cancer patients.Keywords
This publication has 41 references indexed in Scilit:
- Coagulation monitoring of the bleeding traumatized patientCurrent Opinion in Anaesthesiology, 2012
- Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis GuidelinesChest, 2012
- FIBTEM provides early prediction of massive transfusion in traumaCritical Care, 2011
- A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution‐induced coagulation changes after cardiac surgeryTransfusion, 2011
- Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized studyJournal of Thrombosis and Haemostasis, 2010
- Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgeryBritish Journal of Cancer, 2009
- Assessing Risk of Venous Thromboembolism in the Patient With CancerJournal of Clinical Oncology, 2009
- Hypercoagulable state associated with kidney–pancreas transplantation. Thromboelastogram‐directed anti‐coagulation and implications for future therapyClinical Transplantation, 2004
- Thromboelastography for Monitoring Prolonged Hypercoagulability After Major Abdominal SurgeryAnesthesia & Analgesia, 2001
- Blutgerinnungsstudien mit der Thrombelastographie, einem neuen UntersuchungsverfahrenJournal of Molecular Medicine, 1948